Learn More
Medchemexpress LLC Incb086550 | 2230911-59-6 | 99.8% | C41H39N7O4 | 10MG

Supplier: Medchemexpress LLC HY13488410MG
INCB086550 is an orally available, small-molecule inhibitor of programmed death-ligand 1 (PD-L1) used as a research reagent for preclinical and translational studies. It has been characterized in published preclinical work and referenced in early clinical development documents, and is supplied at high purity for biological assays.
- Orally available small-molecule PD-L1 inhibitor.
- High potency against PD-L1 (human IC50 ~3.1 nM).
- High purity suitable for biological studies (99.8%).
- Characterized in preclinical models and referenced in clinical development literature.
- Provided in small, research-scale quantities for assay development and in vivo studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.